Yahoo
Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences (PRHSX)

98.63 +0.67 (+0.68%)
As of 8:10:22 AM EDT. Market Open.

Top 9 Holdings (47.09% of Total Assets)

Symbol Company % Assets
LLY 13.04%
JNJ 6.75%
MRK 5.49%
UNH 5.41%
ABBV 5.41%
TMO 3.26%
GILD 2.99%
AMGN 2.43%
ABT 2.32%

Sector Weightings

Overall Portfolio Composition (%)

Cash 0.63%
Stocks 91.58%
Bonds 0.01%
Others 7.68%
Preferred 0.00%
Convertible 0.11%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average PRHSX Category Average
Price/Earnings
0.03 24.55
Price/Book
0.17 5.28
Price/Sales
0.39 2.06
Price/Cashflow
0.05 17.54
Median Market Cap
119,913.05 34,862.81
3 Year Earnings Growth
16.94 32.48

Bond Holdings

Average PRHSX Category Average
Maturity
-- --
Duration
2.5 --
Credit Quality
-- --

Performance & Risk

YTD Return 17.26%
5y Average Return 4.91%
Rank in Category (ytd) 46
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.62
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family T. Rowe Price
Net Assets 12.24B
YTD Return 12.83%
Yield 0.10%
Morningstar Rating
Inception Date Dec 29, 1995

Fund Summary

The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.

Top Mutual Funds

Mobilize your Website
View Site in Mobile | Classic
Share by: